CAD system identifies abnormalities in breast sonograms
Cedara Software is developing a computer-assisted detection system for breast ultrasound. The software, announced as a work-in-progress at the RSNA meeting, is intended to identify the sonographic characteristics of benign as well as malignant breast masses and to classify the extent of malignancy for specific nodules.
Cedara Software is developing a computer-assisted detection system for breast ultrasound. The software, announced as a work-in-progress at the RSNA meeting, is intended to identify the sonographic characteristics of benign as well as malignant breast masses and to classify the extent of malignancy for specific nodules.
The company is evolving four configurations of the breast CAD system, which require FDA approval before commercialization in the U.S. B-CAD will identify features of user-defined lesions that correspond to the BI-RADS lexicon in ultrasound images. B-CAD Plus, in addition to flagging user-defined breast lesions, will use sonographic characteristics to compute the probability of malignancy. B-CAD Pro will identify breast lesions and their features. B-CAD Live will provide all the features of the other CAD options in real-time.
The Cedara B-CAD technology was based on the analysis of more than 1400 images and data from patients with healthy breast tissue, as well as cases with known clinical outcomes following the diagnosis of a breast malignancy.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
FDA Clears Ultrasound AI Detection for Pleural Effusion and Consolidation
June 18th 2025The 14th FDA-cleared AI software embedded in the Exo Iris ultrasound device reportedly enables automated detection of key pulmonary findings that may facilitate detection of pneumonia and tuberculosis in seconds.
Can Contrast-Enhanced Mammography be a Viable Screening Alternative to Breast MRI?
June 17th 2025While the addition of contrast-enhanced mammography (CEM) to digital breast tomosynthesis (DBT) led to over a 13 percent increase in false positive cases, researchers also noted over double the cancer yield per 1,000 women in comparison to DBT alone.
